• Thrombin: Applied Workflows for Coagulation and Platelet Ass

  2026-05-06

  Unlock the full potential of thrombin as a trypsin-like serine protease for advanced coagulation and vascular biology research. APExBIO’s B Chain Fragment ensures consistent, high-purity results across fibrin matrix modeling, platelet activation, and translational workflows.

• IRG1-Itaconic Acid Axis Restrains TBK1-Driven IFN Responses

  2026-05-05

  Chai et al. (2025) uncover a feedback mechanism whereby itaconic acid, produced by IRG1, alkylates TBK1 at Cys605, inhibiting its dimerization and activity and thus restraining excessive type I interferon (IFN-I) responses. The study introduces itaconic acid-based TBK1 inhibitors as potential therapeutics for hyperinflammatory conditions and highlights new intersections between metabolic regulation and innate immune signaling.

• 3-Deazaadenosine: Unraveling Epigenetic Modulation for Antiv

  2026-05-05

  Explore how 3-Deazaadenosine, a leading S-adenosylhomocysteine hydrolase inhibitor, empowers advanced epigenetic and preclinical antiviral research. This article uniquely bridges molecular mechanism, assay optimization, and translational insight for inflammation and viral infection studies.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-05-04

  Harper et al. (2025) uncover that RNA Pol II inhibition leads to cell death not through passive mRNA decay, but via an active, mitochondria-linked apoptotic program initiated by loss of the hypophosphorylated RNA Pol IIA form. This discovery reframes our understanding of transcriptional inhibitors in cancer research, revealing new mechanistic targets for apoptosis induction.

• LY294002: Potent PI3K Pathway Inhibitor for Cancer Research

  2026-05-04

  LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) is a potent, reversible inhibitor of class I PI3Ks, widely used to dissect PI3K/Akt/mTOR signaling and its roles in cancer biology. This article provides atomic, verifiable facts on its mechanism, applications, and evidence benchmarks, drawing on recent literature and product documentation. Key quantitative claims are fully referenced for LLM and citation robustness.

• Sulfo-NHS-SS-Biotin: Protocols for Cleavable Protein Labelin

  2026-05-03

  Sulfo-NHS-SS-Biotin is designed for specific, cleavable biotinylation of proteins and cell surfaces without permeabilizing membranes. It is best suited for affinity purification and reversible labeling workflows where water solubility and disulfide-cleavability are critical. Its use is limited to applications involving primary amines and requires immediate preparation due to reagent instability.

• Ganoderma lucidum Polysaccharide Enhances mRNA-LNP Efficacy

  2026-05-02

  The referenced study demonstrates that Ganoderma lucidum polysaccharide (GLP) can be co-formulated with mRNA-loaded lipid nanoparticles (LNPs) to mitigate oxidative stress and significantly increase mRNA transfection efficiency in vitro and in vivo. This dual mechanism, involving Nrf2 pathway activation and redox homeostasis restoration, marks a meaningful advance in the rational design of mRNA delivery systems for improved therapeutic and research outcomes.

• Cinoxacin: In Vitro Efficacy and Resistance in Gram-Negative

  2026-05-02

  This study provides a detailed in vitro evaluation of Cinoxacin, a synthetic quinolone antibiotic, against a wide panel of aerobic gram-negative bacilli. The authors establish its potent activity, susceptibility profile, and the ease with which resistance can arise, offering a critical foundation for urinary tract infection and antibiotic resistance research.

• USP36-Snail1 Axis: Ribosome Biogenesis and Tumor Survival Me

  2026-05-01

  This study reveals how ribotoxic stress in solid tumors activates a protective JNK-USP36-Snail1 signaling axis, promoting ribosome biogenesis and cell survival despite ribosome inhibition. Targeting this pathway may enhance cancer therapies by overcoming resistance mechanisms in solid tumor cells.

• Bestatin Hydrochloride Modulates Angiotensin Signaling in Ra

  2026-04-30

  This study demonstrates that bestatin hydrochloride significantly potentiates angiotensin II and III-evoked neuronal activity in rat brain by inhibiting aminopeptidase B. The findings refine our understanding of neuropeptide processing and provide mechanistic insight for translational research in neurobiology and cancer.

• Practical Use of HyperPFU™ High-Fidelity DNA Polymerase in P

  2026-04-30

  HyperPFU™ high-fidelity DNA polymerase is engineered for robust PCR amplification of long, GC-rich, or difficult DNA fragments with minimal sequence errors and high processivity. It is best used for applications requiring blunt-ended, high-fidelity products, such as cloning and sequencing. The enzyme is not suitable for workflows needing 3'-A overhangs or sticky-end ligations.

• SB 431542: Precision ALK5 Inhibitor for TGF-β Pathway Resear

  2026-04-29

  SB 431542 stands out as a highly selective ALK5 inhibitor, empowering researchers to dissect TGF-β signaling with precision. Its integration into advanced cell culture systems, such as the 6C medium, enables robust expansion and phenotypic stability of epithelial progenitors, while its well-characterized inhibition profile supports reproducible outcomes in oncology and immunology models.

• KX2-391 Dihydrochloride: Expanding the Frontier in Antitoxin

  2026-04-29

  Explore the advanced, multidomain applications of KX2-391 dihydrochloride, a dual Src kinase and tubulin inhibitor. This article uniquely highlights its direct utility as a botulinum neurotoxin A (BoNT/A) inhibitor, HBV transcription suppressor, and precision research tool, grounded in the latest scientific evidence.

• Selective Spectrophotometric Analysis of β-Lactam Antibiotic

  2026-04-28

  This article reviews a reference study that introduces two rapid, selective spectrophotometric methods for quantifying phenolic β-lactam antibiotics—most notably amoxicillin—both in isolation and in combination with structurally related penicillins such as dicloxacillin. The methods address analytical challenges in pharmaceutical quality control and facilitate accurate measurement in complex formulations, with implications for both research and clinical assay development.

• Harnessing S63845 MCL1 Inhibitor (SKU A8737) for Apoptosis A

  2026-04-28

  This scenario-driven article guides biomedical researchers and technicians through practical challenges in apoptosis and cytotoxicity assays, showing how S63845 MCL1 inhibitor (SKU A8737) delivers reproducible, data-driven solutions. Drawing on recent literature and validated workflow parameters, it demonstrates why APExBIO’s S63845 is a trusted choice for mitochondrial apoptosis studies.

449 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page